We are live on ! Find out more
PHVS icon

Pharvaris

25 hedge funds and large institutions have $240M invested in Pharvaris in 2022 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

80% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 5

67% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 3

50% more funds holding in top 10

Funds holding in top 10: 23 (+1)

38% more capital invested

Capital invested by funds: $174M → $240M (+$66M)

19% more funds holding

Funds holding: 2125 (+4)

3.06% less ownership

Funds ownership: 67.32%64.26% (-3.1%)

Holders
25
Holders Change
+4
Holders Change %
+19.05%
% of All Funds
0.4%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.05%
New
9
Increased
5
Reduced
3
Closed
5
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$37.3M +$263 +50 +0%
FCMI
2
Foresite Capital Management IV
California
$36.5M
Viking Global Investors
3
Viking Global Investors
Connecticut
$36.4M +$3.87M +735,000 +29%
BCLSI
4
Bain Capital Life Sciences Investors
Massachusetts
$35.8M
GA
5
General Atlantic
New York
$27.2M
VP
6
venBio Partners
California
$25.8M
NHAS
7
Novo Holdings A/S
Denmark
$13.4M +$3.04M +577,307 +95%
CAM
8
Cormorant Asset Management
Massachusetts
$9.19M -$2.06M -391,040 -32%
5VM
9
5AM Venture Management
California
$6.61M
SCM
10
Soleus Capital Management
Connecticut
$3.49M +$1.63M +310,000 New
SCM
11
Sio Capital Management
New York
$3.21M +$1.5M +285,000 New
Walleye Capital
12
Walleye Capital
New York
$1.7M +$796K +151,329 New
SCM
13
Silverarc Capital Management
Massachusetts
$1.13M +$526K +100,000 New
Morgan Stanley
14
Morgan Stanley
New York
$430K +$100K +19,085 +100%
FCMV
15
Foresite Capital Management V
California
$384K
LCM
16
Lynx1 Capital Management
Puerto Rico
$285K +$133K +25,325 New
Geode Capital Management
17
Geode Capital Management
Massachusetts
$209K
SSA
18
Schonfeld Strategic Advisors
New York
$183K +$85.7K +16,300 New
TRCT
19
Tower Research Capital (TRC)
New York
$146K +$50.1K +9,533 +276%
QT
20
Quantamental Technologies
New York
$145K +$67.8K +12,900 New
Millennium Management
21
Millennium Management
New York
$116K -$528K -100,380 -91%
UBS Group
22
UBS Group
Switzerland
$31.5K +$14.7K +2,800 New
FIA
23
FNY Investment Advisers
New York
$9K +$4.63K +880 New
BlackRock
24
BlackRock
New York
$1.75K
Bank of America
25
Bank of America
North Carolina
$11 -$47K -8,941 -100%

PHVS Hedge Fund Activity: Q4 2022 in Review

25 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in Pharvaris (PHVS) for Q4 2022, worth a combined $240M — up 38% from $174M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new PHVS positions and 5 closed out — a net gain of 4 holders — while 5 added to existing stakes and 3 trimmed.

The largest buyer was Viking Global Investors, adding an estimated $3.87M. The largest seller was Deerfield Management, exiting entirely with an estimated $8.47M sold.

  • 25 institutional investors held Pharvaris (PHVS) as of Q4 2022, up from 21 in Q3 2022.
  • Funds reported $240M of Pharvaris stock for Q4 2022, up 38% quarter-over-quarter.
  • 9 funds opened new Pharvaris positions in Q4 2022 and 5 closed out, a net change of +4 holders.
  • The largest Pharvaris buyer in Q4 2022 was Viking Global Investors, an estimated $3.87M added.
  • The largest Pharvaris seller in Q4 2022 was Deerfield Management, an estimated $8.47M sold.

Based on aggregated 13F filings for Q4 2022.